Akcie v oběhu společnosti Æterna Zentaris
Jaká je hodnota metriky Akcie v oběhu společnosti Æterna Zentaris?
Hodnota metriky Akcie v oběhu společnosti Æterna Zentaris, Inc. je 4.844M 99.75%
Jaká je definice metriky Akcie v oběhu?
Akce v oběhu (Shares float) je podíl akcií společnosti vlastněných veřejnými investory vůči zablokovaným akcím (nejsou volně v oběhu).
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Akcie v oběhu společností v sektoru Health Care sektor na TSX ve srovnání se společností Æterna Zentaris
Čemu se věnuje společnost Æterna Zentaris?
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Firmy s metrikou akcie v oběhu podobnou společnosti Æterna Zentaris
- Hodnota metriky Akcie v oběhu společnosti Technofab Engineering je 4.824M 45.99%
- Hodnota metriky Akcie v oběhu společnosti Jash Engineering je 4.824M 40.76%
- Hodnota metriky Akcie v oběhu společnosti Esports Entertainment je 4.826M
- Hodnota metriky Akcie v oběhu společnosti Bal Pharma je 4.834M 34.11%
- Hodnota metriky Akcie v oběhu společnosti Pinetree Capital je 4.836M 51.52%
- Hodnota metriky Akcie v oběhu společnosti Kina Petroleum je 4.842M 37.77%
- Hodnota metriky Akcie v oběhu společnosti Æterna Zentaris je 4.844M 99.75%
- Hodnota metriky Akcie v oběhu společnosti FFP Societe anonyme je 4.847M 19.55%
- Hodnota metriky Akcie v oběhu společnosti Bisichi PLC je 4.847M 45.40%
- Hodnota metriky Akcie v oběhu společnosti Novotek AB je 4.854M
- Hodnota metriky Akcie v oběhu společnosti FP Newspapers je 4.860M 70.41%
- Hodnota metriky Akcie v oběhu společnosti SES-imagotag SA je 4.866M 30.89%
- Hodnota metriky Akcie v oběhu společnosti Kaya je 4.868M 37.26%